Homozygous defect in HIV-1 coreceptor accounts for resistance of some multiply-exposed individuals to HIV-1 infection
- PMID: 8756719
- DOI: 10.1016/s0092-8674(00)80110-5
Homozygous defect in HIV-1 coreceptor accounts for resistance of some multiply-exposed individuals to HIV-1 infection
Abstract
Rare individuals have been multiply exposed to HIV-1 but remain uninfected. The CD4+ T-cells of two of these individuals, designated EU2 and EU3, are highly resistant in vitro to the entry of primary macrophagetropic virus but are readily infectable with transformed T-cell line adapted viruses. We report here on the genetic basis of this resistance. We found that EU2 and EU3 have a homozygous defect in CKR-5, the gene encoding the recently described coreceptor for primary HIV-1 isolates. These individuals appear to have inherited a defective CKR-5 allele that contains an internal 32 base pair deletion. The encoded protein is severely truncated and cannot be detected at the cell surface. Surprisingly, this defect has no obvious phenotype in the affected individuals. Thus, a CKR-5 allele present in the human population appears to protect homozygous individuals from sexual transmission of HIV-1. Heterozygous individuals are quite common (approximately 20%) in some populations. These findings indicate the importance of CKR-5 in HIV-1 transmission and suggest that targeting the HIV-1-CKR-5 interaction may provide a means of preventing or slowing disease progression.
Similar articles
-
Mutant gene blocks HIV's entry into cells.NIAID AIDS Agenda. 1996 Sep:6. NIAID AIDS Agenda. 1996. PMID: 11363925
-
Genetic restriction of HIV-1 infection and progression to AIDS by a deletion allele of the CKR5 structural gene. Hemophilia Growth and Development Study, Multicenter AIDS Cohort Study, Multicenter Hemophilia Cohort Study, San Francisco City Cohort, ALIVE Study.Science. 1996 Sep 27;273(5283):1856-62. doi: 10.1126/science.273.5283.1856. Science. 1996. PMID: 8791590
-
HIV-1 infection in an individual homozygous for the CCR5 deletion allele.Nat Med. 1997 Mar;3(3):252-3. doi: 10.1038/nm0397-252. Nat Med. 1997. PMID: 9055842 No abstract available.
-
Host genes and HIV: the role of the chemokine receptor gene CCR5 and its allele.Emerg Infect Dis. 1997 Jul-Sep;3(3):261-71. doi: 10.3201/eid0303.970302. Emerg Infect Dis. 1997. PMID: 9284370 Free PMC article. Review.
-
Coreceptor-Based Hematopoietic Stem Cell Gene Therapy for HIV Disease.Curr Stem Cell Res Ther. 2019;14(7):591-597. doi: 10.2174/1574888X14666190523094556. Curr Stem Cell Res Ther. 2019. PMID: 31120000 Review.
Cited by
-
Progress Note 2024: Curing HIV; Not in My Lifetime or Just Around the Corner?Pathog Immun. 2024 Mar 1;8(2):115-157. doi: 10.20411/pai.v8i2.665. eCollection 2023. Pathog Immun. 2024. PMID: 38455668 Free PMC article.
-
The chemokine receptor CCR5: multi-faceted hook for HIV-1.Retrovirology. 2024 Jan 23;21(1):2. doi: 10.1186/s12977-024-00634-1. Retrovirology. 2024. PMID: 38263120 Free PMC article. Review.
-
Transposable elements may enhance antiviral resistance in HIV-1 elite controllers.bioRxiv [Preprint]. 2023 Dec 12:2023.12.11.571123. doi: 10.1101/2023.12.11.571123. bioRxiv. 2023. PMID: 38168352 Free PMC article. Preprint.
-
Computationally defined and in vitro validated putative genomic safe harbour loci for transgene expression in human cells.Elife. 2024 Jan 2;13:e79592. doi: 10.7554/eLife.79592. Elife. 2024. PMID: 38164941 Free PMC article.
-
Challenges of CRISPR/Cas-Based Cell Therapy for Type 1 Diabetes: How Not to Engineer a "Trojan Horse".Int J Mol Sci. 2023 Dec 10;24(24):17320. doi: 10.3390/ijms242417320. Int J Mol Sci. 2023. PMID: 38139149 Free PMC article. Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases
Research Materials
